The Muscle-Bound Heart

dc.contributor.authorRefaat, Marwan M.
dc.contributor.authorFahed, Akl C.
dc.contributor.authorHassanieh, Sylvana
dc.contributor.authorHotait, Mostafa
dc.contributor.authorArabi, Mariam Toufic
dc.contributor.authorSkouri, Hadi N.
dc.contributor.authorSeidman, Jonathan G.
dc.contributor.authorSeidman, Christine E.
dc.contributor.authorBitar, Fadi Fouad
dc.contributor.authorNemer, Georges M.
dc.contributor.departmentInternal Medicine
dc.contributor.departmentBiochemistry and Molecular Genetics
dc.contributor.departmentPediatrics and Adolescent Medicine
dc.contributor.departmentCardiac Electrophysiology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:48:42Z
dc.date.available2025-01-24T11:48:42Z
dc.date.issued2016
dc.description.abstractHypertrophic cardiomyopathy (HCM) is a familial cardiac disease manifested in a wide phenotype and diverse genotype and, thus, presenting unpredictable risks mainly on young adults. Extensive studies are being conducted to categorize patients and link phenotype with genotype for a better management and control of the disease with all its complications. Because the full mechanisms behind HCM are still not revealed, therapeutics are not definitive. Further research is to be conducted for the generation of a complete picture and directed therapy for HCM. © 2016 Elsevier Inc.
dc.identifier.doihttps://doi.org/10.1016/j.ccep.2015.10.034
dc.identifier.eid2-s2.0-84959869801
dc.identifier.pmid26920199
dc.identifier.urihttp://hdl.handle.net/10938/30836
dc.language.isoen
dc.publisherW.B. Saunders
dc.relation.ispartofCardiac Electrophysiology Clinics
dc.sourceScopus
dc.subjectGenotype
dc.subjectHypertrophic cardiomyopathy
dc.subjectLeft ventricle
dc.subjectMuscle-bound heart
dc.subjectPhenotype
dc.subjectAdult
dc.subjectAtrial fibrillation
dc.subjectCardiomyopathy, hypertrophic
dc.subjectCatheter ablation
dc.subjectHumans
dc.subjectMale
dc.subjectPedigree
dc.subjectAntiarrhythmic agent
dc.subjectBeta adrenergic receptor blocking agent
dc.subjectCalcium channel blocking agent
dc.subjectDiltiazem
dc.subjectDisopyramide
dc.subjectDiuretic agent
dc.subjectDisease control
dc.subjectDyspnea
dc.subjectFamilial disease
dc.subjectGenetic predisposition
dc.subjectGenetic risk
dc.subjectGenetic screening
dc.subjectGenetic susceptibility
dc.subjectGenetic variability
dc.subjectHeart atrium flutter
dc.subjectHeart left ventricle outflow tract obstruction
dc.subjectHeart murmur
dc.subjectHeart palpitation
dc.subjectHuman
dc.subjectHypertrophic nonobstructive cardiomyopathy
dc.subjectMolecular pathology
dc.subjectPriority journal
dc.subjectReview
dc.subjectSymptom
dc.subjectTransthoracic echocardiography
dc.subjectCase report
dc.titleThe Muscle-Bound Heart
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2016-4826.pdf
Size:
495.84 KB
Format:
Adobe Portable Document Format